MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia

September 24th 2024, 3:00pm

Article

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS.

In a World of Rushing, Cancer Taught Me to Slow Down

September 20th 2024, 5:00pm

Article

With my myelodysplastic syndrome and age, I find it hard to keep up; however, cancer and fatigue have taught me to live at my own pace.

Infections May Impact Survival, Quality of Life in Patients With MDS

September 19th 2024, 3:00pm

Article

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, researchers urged.

Why Transfusion Independence Matters for Patients With MDS

September 18th 2024, 7:00pm

Article

An expert explained the burden that red blood cell transfusions can place on patients with MDS.

My Worries About Being Old as an MDS Survivor

September 6th 2024, 5:00pm

Article

Having myelodysplastic syndromes has taught me to cherish every day and to pursue the things that matter to me, like publishing a book I’ve been writing.

‘Tempo’ of MDS Helps With Timing for Stem Cell Transplants

September 5th 2024, 7:00pm

Video

For patients with MDS, close monitoring by doctors may help determine the appropriate timing to undergo stem cell transplants before the disease worsens.